Mold-Tek Packaging profit rises 14% in Q1FY27 on consolidation gains
Mold-Tek Packaging's Q1FY27 results show a 14.19% increase in net profit to ₹25.57 crore and a 24.90% rise in revenue to ₹300.45 crore. The performance was driven by operational consolidation in Hyderabad and strong volume growth in pharma and food segments, offsetting headwinds in lube packs.
*this image is generated using AI for illustrative purposes only.
Mold-Tek Packaging reported a 14.19% year-on-year increase in net profit to ₹25.57 crore for the quarter ended June 30, 2026, driven by strategic consolidation of its Hyderabad manufacturing units and robust growth in the pharma segment. The company’s net sales rose 24.90% to ₹300.45 crore, crossing the ₹300 crore mark for the first time, while EBITDA per kilogram reached a historical high of ₹46.68. This performance underscores the effectiveness of its operational restructuring in mitigating input cost pressures and enhancing margin stability despite geopolitical uncertainties.
The Board of Directors approved the unaudited financial results on July 27, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by M.Anandam & Co., the statutory auditors, who issued a limited review report confirming compliance with Ind AS 34 and other generally accepted accounting principles in India. Chairman and Managing Director J Lakshmana Rao highlighted that the company has successfully navigated global supply chain disruptions to deliver quality supplies on time.
Financial Performance
Mold-Tek Packaging delivered robust top-line growth, with revenue from operations increasing from ₹240.56 crore in Q1FY26 to ₹300.45 crore in Q1FY27. This growth was supported by a 6.25% rise in sales volume to 12,089 MT. Profit before tax (PBT) grew 13.86% to ₹34.17 crore. The company maintained strong profitability metrics despite geopolitical uncertainties, effectively passing on higher input costs to customers. Cash PAT rose 15.61% to ₹42.12 crore, reflecting improved cash conversion.
| Metric: | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Revenue from Operations: | ₹300.45 crore | ₹240.56 crore | +24.90% |
| EBITDA: | ₹56.43 crore | ₹47.38 crore | +19.11% |
| EBITDA Margin: | 18.78% | 19.70% | -92 bps |
| Profit Before Tax: | ₹34.17 crore | ₹30.01 crore | +13.86% |
| Net Profit (PAT): | ₹25.57 crore | ₹22.40 crore | +14.19% |
| Sales Volume (MT): | 12,089 | 11,378 | +6.25% |
| EBITDA per kg: | ₹46.68 | ₹41.64 | +12% |
Segment-Wise Growth and New Wins
The pharma packaging vertical emerged as a key growth driver, posting a 38.75% sales volume growth due to rapid client acquisition and new product introductions. During Q1FY27, the company secured orders from Blackgoldust, Pharma Force Lab, Pure Source Nutrition Pvt Ltd, and Topiox Research Centre Pvt Ltd. Food & FMCG packs registered a 26.20% volume growth, supported by deeper market penetration and doubled production capacity at the Panipat facility. New customers in this segment included Innovative Food, Alphonsa Cashew, Bakerville Specialities, Beejapuri Daily, DS Agrotech, Sam Flour & Spices, SGB Food, and Veg Crop Agro.
Paints packs saw a 10.82% growth, benefiting from steady industry demand. Conversely, the Lube Packs segment faced headwinds due to supply issues of client inputs linked to geopolitical tensions, leading to a dip in demand. Chairman and Managing Director J Lakshmana Rao attributed the overall performance to the consolidation of five Hyderabad units into two major facilities at Annaram and Sultanpur over the last six months.
Operational Consolidation and Capacity Expansion
The consolidation streamlined printing activities under one roof, reducing overheads, inter-unit transfers, and rejections. Capacity utilization reached 75%, contributing to the record EBITDA per kg. To meet rising demand, the company commissioned additional molding and assembly machines for the pharma segment and eight new injection moulding machines at its Sultanpur facility for Food & FMCG products. Strategic logistics planning also helped substantially reduce transportation costs for labels across its Indian manufacturing units.
What the Numbers Show
The divergence between revenue growth (24.90%) and volume growth (6.25%) indicates a significant contribution from price realization or mix shift towards higher-margin products like pharma packaging. The year-on-year contraction in EBITDA margin to 18.78% from 19.70% reflects the impact of higher input costs, even as the record EBITDA per kg confirms that operational efficiencies from unit consolidation are translating into improved cost control. This suggests the company is navigating input cost volatility through pricing power while continuing to scale its higher-margin segments.
Historical Stock Returns for Mold-Tek Packaging
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.86% | -1.55% | -2.37% | +27.81% | -7.10% | +31.57% |
How sustainable is the record EBITDA per kg of ₹46.68 if input costs continue to rise due to ongoing geopolitical tensions?
What is the expected timeline for the newly commissioned injection moulding machines at Sultanpur to reach full capacity utilization and impact bottom-line margins?
Will the continued consolidation of Hyderabad units lead to further cost synergies in Q2FY27, or have the primary efficiency gains already been realized?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
